The Association of Corporate Counsel (ACC) is the world's largest organization serving the professional and business interests of attorneys who practice in the legal departments of corporations, associations, nonprofits and other private-sector organizations around the globe.
The COVID-19 pandemic has led many companies to lose significant revenue due to their businesses being interrupted. With the ‘back to business’ timeline still unknown, many questions arise whether companies can leverage business interruption coverage for protection, and if so, how? Join Newmeyer Dillion as we dissect the current insurance environment to:
Understand the insurance carrier landscape: their reaction & how they are gearing up for this fight
Dig into the legislative and government approach: how the government is being proactive and the potential impact on claims
Uncover the Insurance Commissioner update: the California approach to these claims
Spotlight existing case law & examine how courts have approached these incidents in the past, and what arguments may be applicable in today’s world
Review pending litigation to provide an overview of the plethora of bus interruption insurance cases that are pending and their overarching trends
Attendees will walk away with ND’s Top 5 practical tips to approaching business interruption coverage, along with a 30 minute Q&A session to answer your pressing questions immediately following the presentation.
Presenters: Alan Packer, Office Managing Partner, Newmeyer Dillion Jeff Dennis, Partner, Newmeyer Dillion
Although the time to commence or respond to formal claims may still be in the future, the time is now to prepare yourself and your business to best leverage possible solutions and avoid litigation.
The COVID-19 pandemic has caused massive economic disruptions for businesses large and small. No company wants to find itself in litigation, yet numerous commercial contract disputes are already emerging as a result of:
• large-scale cancellations or postponements of orders;
• disruptions to key supply chains; • restrictions on business operations;
• the accessibility and cost of credit issues;
• the patchwork of state, local and federal laws that have been enacted in response to the virus and its effects; and
• the risks of working and transacting business remotely.
Partners Mindy Morton, Robert Sloss and Edward Walton will respond to your questions and address key issues related to conflict resolution and litigation avoidance with a focus on contract provisions, including force majeure contract clauses. Every contract is unique and provisions are always subject to interpretation, but a solid understanding of the parameters of your contracts and possible risks will better prepare you when working with counsel on avoiding litigation and resolving disputes.
This is part of a series of ACC member roundtables.
ACC member roundtables are designed exclusively for in-house counsel to virtually meet and discuss current issues in their industry.
Grab your drink of choice and let's connect! Join us for a lively virtual happy hour and networking event where ACC Members will have the opportunity to introduce themselves, connect with each other and discuss what many companies are facing or will likely face when this hard-hit industry bounces back once the "Stay at Home" order begins to lift.
Panelists: Mark Hartney, Partner, Allen Matkins Paul Najar, Vice President, General Counsel and Corporate Secretary, Gafcon Kathryn Richman, General Counsel, Hughes Marino
Shutdown orders due to the COVID-19 virus pandemic have created economic disruption, causing companies to scale back on intellectual property (IP) expense. This webinar covers suggestions for protecting IP on a reduced budget. The strategies presented will provide attendees with a competitive edge over competitors who are sitting on the IP sidelines during the pandemic.
Some of the topics covered include:
why getting in line early and maintaining a place in line at the Patent Office is crucial to protect your patentable inventions;
how to reserve and maintain your place in line at the Patent Office while reducing and/or deferring certain examination-related expenses;
how to use existing patent prosecution techniques to achieve these goals without relying on potentially risky newly-available COVID-19 options from the Patent Office;
how to use certain techniques related to claim drafting, patent family and portfolio filing strategies, and international patent practice to reduce costs; and
using non-patent approaches to protecting certain IP.
Has COVID-19 delayed CCPA Compliance? Listen as a panel of leaders share their top tips to get your company ready before enforcement begins in July 2020.
Session 1: Checklist for CCPA Compliance in the COVID-19 Age
11:00 am - 11:45 am PT | Program
11:45 pm - 12:00 pm PT | Q&A
Speakers: Dominique Shelton Leipzig, Firmwide Co-Chair, Ad Tech Privacy & Data Management Practice Njeri Mutura, Corporate Attorney, Lead Counsel, Microsoft Joni Gaudes, VP & General Counsel, Asics America
Session 2: Top Litigation and Contracts Risks for CCPA and COVID-19
12:00 pm - 12:45 pm PT | Program
12:45 pm - 1:00 pm PT | Q&A
Over the coming weeks, many employers are welcoming their employees back to work. Re-starting operations will raise new and difficult challenges for employers. PPSC’s COVID-19 team will provide practical advice on addressing these challenges.
Topics will include:
Deciding when to re-start, and who to bring back
Providing a safe workplace
Employee testing
Adjusting pay and schedules
Dealing with employees who do not want to return to work
Managing obligations to vulnerable employees
Reinstatement obligations under the FFCRA
Latest FFCRA guidance from the Department of Labor
Effective January 1, 2020, the California Consumer Privacy Act imposed a new data privacy paradigm that reaches well beyond California. Your company is almost certainly a “Business” or a “Service Provider” under the CCPA, and it may be both. Join us to discuss particular contracting requirements imposed by CCPA, as well as best practices to consider for Businesses or Service Providers trying to minimize liability.
This program will cover the basic structure of common financial terms in license agreements. All financial terms are not created equal. We will discuss some of the most important issues to consider in structuring and drafting these financial terms, and pay close attention to how these terms may affect your future business.
Join Mintz for the next installment in our COVID-19 webinar series for life sciences companies. This session will explore the widespread disruptions the crisis is posing to clinical trials for life sciences companies and to research study sites. We will also discuss recent guidance from regulatory authorities and practical steps for both sponsors and researchers to address emerging issues.
The program will cover the following topics:
Regulatory authority accommodations for ongoing clinical trials that may be affected by COVID-19 and regional restrictions
Overview of the current clinical trials landscape during the COVID-19 pandemic
Key considerations for sponsors and study sites regarding ongoing and planned clinical trials
Considerations for companies interested in commencing a clinical trial for a COVID-19 product candidate
Speakers: Dianne J. Bourque,Member, Health Law Practice / Clinical Trials & Research, Mintz Benjamin M. Zegarelli, Associate, Health Law Practice / Clinical Trials & Research, Mintz
